Vedolizumab in der Behandlung der Colitis ulcerosa und des Morbus Crohn - ein Konsensus der Arbeitsgruppe "Chronisch Entzündliche Darmerkrankungen" der Österreichischen Gesellschaft für Gastroenterologie und Hepatologie

Z Gastroenterol. 2016 May;54(5):456-67. doi: 10.1055/s-0042-103694. Epub 2016 Mar 16.
[Article in German]
No abstract available

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Austria
  • Colitis, Ulcerative / diagnosis*
  • Colitis, Ulcerative / drug therapy*
  • Crohn Disease / diagnosis*
  • Crohn Disease / drug therapy*
  • Dose-Response Relationship, Drug
  • Drug Administration Schedule
  • Evidence-Based Medicine
  • Gastroenterology / standards
  • Gastrointestinal Agents / administration & dosage
  • Humans
  • Practice Guidelines as Topic*
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • Gastrointestinal Agents
  • vedolizumab